Evidence map›Paper›PMID 37542262›Full record

ArticleBMC medicine2023

CSF1R regulates schizophrenia-related stress response and vascular association of microglia/macrophages.

Ling Yan, Yanli Li, Fengmei Fan, Mengzhuang Gou, Fangling Xuan, Wei Feng, Keerthana Chithanathan, Wei Li, Junchao Huang, Hongna Li and 8 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 3 countries.

Ling Yan *Institute of Biomedicine and Translational Medicine, Faculty of Medicine, University of Tartu, Tartu, Estonia.
Yanli Li *Psychiatry Research Centre, Beijing Huilongguan Hospital, Peking University Health Science Center, Peking University HuiLongGuan Clinical Medical School, Beijing, P. R. China.
Fengmei FanPsychiatry Research Centre, Beijing Huilongguan Hospital, Peking University Health Science Center, Peking University HuiLongGuan Clinical Medical School, Beijing, P. R. China.
Mengzhuang GouPsychiatry Research Centre, Beijing Huilongguan Hospital, Peking University Health Science Center, Peking University HuiLongGuan Clinical Medical School, Beijing, P. R. China.
Fangling XuanInstitute of Biomedicine and Translational Medicine, Faculty of Medicine, University of Tartu, Tartu, Estonia.
Wei FengPsychiatry Research Centre, Beijing Huilongguan Hospital, Peking University Health Science Center, Peking University HuiLongGuan Clinical Medical School, Beijing, P. R. China.
Keerthana ChithanathanInstitute of Biomedicine and Translational Medicine, Faculty of Medicine, University of Tartu, Tartu, Estonia.
Wei LiPsychiatry Research Centre, Beijing Huilongguan Hospital, Peking University Health Science Center, Peking University HuiLongGuan Clinical Medical School, Beijing, P. R. China.
Junchao HuangPsychiatry Research Centre, Beijing Huilongguan Hospital, Peking University Health Science Center, Peking University HuiLongGuan Clinical Medical School, Beijing, P. R. China.
Hongna LiPsychiatry Research Centre, Beijing Huilongguan Hospital, Peking University Health Science Center, Peking University HuiLongGuan Clinical Medical School, Beijing, P. R. China.
Wenjin ChenPsychiatry Research Centre, Beijing Huilongguan Hospital, Peking University Health Science Center, Peking University HuiLongGuan Clinical Medical School, Beijing, P. R. China.
Baopeng TianPsychiatry Research Centre, Beijing Huilongguan Hospital, Peking University Health Science Center, Peking University HuiLongGuan Clinical Medical School, Beijing, P. R. China.
Zhiren WangPsychiatry Research Centre, Beijing Huilongguan Hospital, Peking University Health Science Center, Peking University HuiLongGuan Clinical Medical School, Beijing, P. R. China.
Shuping TanPsychiatry Research Centre, Beijing Huilongguan Hospital, Peking University Health Science Center, Peking University HuiLongGuan Clinical Medical School, Beijing, P. R. China.
Alexander ZharkovskyInstitute of Biomedicine and Translational Medicine, Faculty of Medicine, University of Tartu, Tartu, Estonia.
L Elliot HongDepartment of Psychiatry, School of Medicine, Maryland Psychiatric Research Center, University of Maryland, Baltimore, USA.
Yunlong TanPsychiatry Research Centre, Beijing Huilongguan Hospital, Peking University Health Science Center, Peking University HuiLongGuan Clinical Medical School, Beijing, P. R. China. yltan21@126.com.
Li TianInstitute of Biomedicine and Translational Medicine, Faculty of Medicine, University of Tartu, Tartu, Estonia. li.tian@ut.ee.
Peking University · CNBeijing HuiLongGuan Hospital · CNUniversity of Tartu · EEUniversity of Maryland, Baltimore · US

Funding

The Role of Stress-Immune-Connectome Disruption in Mechanisms of Chinese Early Schizophrenia SpectrumR01MH112180 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI HONG, L ELLIOT ELLIOT · 2017 to 2021
$1.0M
NIMH NIH HHS R01 MH112180
6 · The paper itself

Abstract

backgroundMicroglia are known to regulate stress and anxiety in both humans and animal models. Psychosocial stress is the most common risk factor for the development of schizophrenia. However, how microglia/brain macrophages contribute to schizophrenia is not well established. We hypothesized that effector molecules expressed in microglia/macrophages were involved in schizophrenia via regulating stress susceptibility.

methodsWe recruited a cohort of first episode schizophrenia (FES) patients (n = 51) and age- and sex-paired healthy controls (HCs) (n = 46) with evaluated stress perception. We performed blood RNA-sequencing (RNA-seq) and brain magnetic resonance imaging, and measured plasma level of colony stimulating factor 1 receptor (CSF1R). Furthermore, we studied a mouse model of chronic unpredictable stress (CUS) combined with a CSF1R inhibitor (CSF1Ri) (n = 9 ~ 10/group) on anxiety behaviours and microglial biology.

resultsFES patients showed higher scores of perceived stress scale (PSS, p < 0.05), lower blood CSF1R mRNA (FDR = 0.003) and protein (p < 0.05) levels, and smaller volumes of the superior frontal gyrus and parahippocampal gyrus (both FDR < 0.05) than HCs. In blood RNA-seq, CSF1R-associated differentially expressed blood genes were related to brain development. Importantly, CSF1R facilitated a negative association of the superior frontal gyrus with PSS (p < 0.01) in HCs but not FES patients. In mouse CUS+CSF1Ri model, similarly as CUS, CSF1Ri enhanced anxiety (both p < 0.001). Genes for brain angiogenesis and intensity of CD31

conclusionMicroglial/macrophagic CSF1R regulated schizophrenia-associated stress and brain angiogenesis.

Indexed as

MicrogliaSchizophreniaAnimalsBrainDisease Models, AnimalHumansMacrophagesMiceReceptor, Macrophage Colony-Stimulating FactorReceptors, Granulocyte-Macrophage Colony-Stimulating FactorCSF1R protein, humanCsf1r protein, mouseReceptor, Macrophage Colony-Stimulating FactorReceptors, Granulocyte-Macrophage Colony-Stimulating FactorAngiogenesisAnxietyCSF1RFirst episode schizophreniaMicroglia/Brain macrophagesStress

Identifiers

PMID37542262
PMCPMC10403881
OpenAlexW4385575325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.